Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-05-29

Clinical Trial Update: Phase II Study of RR110 in Patients With Active Crohn's Disease [Phase 2]

View source ↗

Summary

Phase II study of RR110 in patients with active Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RR110

Snippet

Sponsor: R&R Inc. | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED